Jorge Daruich
Overview
Explore the profile of Jorge Daruich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DAmico G, Zipprich A, Villanueva C, Sorda J, Morillas R, Garcovich M, et al.
Hepatology
. 2023 Nov;
79(4):869-881.
PMID: 37916970
Background And Aims: The prognostic weight of further decompensation in cirrhosis is still unclear. We investigated the incidence of further decompensation and its effect on mortality in patients with cirrhosis....
2.
Sorda J, Barreyro F, Rojas G, Greco D, Paes A, Avagnina A, et al.
ACG Case Rep J
. 2023 Aug;
10(8):e01111.
PMID: 37539377
Intrahepatic cholestasis as a paraneoplastic manifestation was first described by Dr. Maurice H. Stauffer in 1961. This paraneoplastic manifestation was primarily associated with renal cell carcinoma characterized by abnormal liver...
3.
Sorda J, Gonzalez Ballerga E, Barreyro F, Daruich J
Aliment Pharmacol Ther
. 2021 Dec;
55(2):249-250.
PMID: 34970761
No abstract available.
4.
Sorda J, Gonzalez Ballerga E, Barreyro F, Avagnina A, Carballo P, de Lima A, et al.
Aliment Pharmacol Ther
. 2021 Sep;
54(9):1202-1212.
PMID: 34587309
Background: Ursodeoxycholic acid (UDCA) is the first-line therapy for primary biliary cholangitis (PBC). However, nearly 40% of patients have an incomplete response to UDCA. The addition of bezafibrate has shown...
5.
Saad A, Aladio J, Yamasato F, Volberg V, Gonzalez Ballerga E, Sorda J, et al.
Curr Probl Cardiol
. 2021 Jun;
47(5):100903.
PMID: 34172315
Hereditary Hemochromatosis (HH) is a genetic condition associated with a systemic iron overload. Heart failure is an important cause of mortality. It has been demonstrated early stages of systolic and...
6.
Martin M, Millan A, Ferraro F, Tetzlaff W, Lozano C, Botta E, et al.
Biosci Rep
. 2020 Oct;
40(10).
PMID: 33026063
Background: Hereditary hemochromatosis (HH) is a primary iron overload (IO) condition. Absolute telomere length (ATL) is a marker of cellular aging and DNA damage associated with chronic diseases and mortality....
7.
Tetzlaff W, Merono T, Botta E, Martin M, Sorroche P, Boero L, et al.
Ann Hematol
. 2018 Apr;
97(9):1683-1687.
PMID: 29656314
Primary iron overload (IO) is commonly associated with mutations in the hereditary hemochromatosis gene (HFE). Nonetheless, other genetic variants may influence the development of IO beyond HFE mutations. There is...
8.
Gonzalez Ballerga E, Pozo M, Rubatto Birri P, Edul V, Sorda J, Daruich J, et al.
Microcirculation
. 2018 Mar;
25(4):e12448.
PMID: 29527776
Objective: To assess sublingual microcirculation in cirrhotic patients and its relationship to spider angiomas, complications, and outcome. Methods: Thirty-one cirrhotic patients were prospectively compared to 31 matched controls. Sublingual microcirculation...
9.
Inzaugarat M, De Matteo E, Baz P, Lucero D, Garcia C, Gonzalez Ballerga E, et al.
PLoS One
. 2017 Mar;
12(3):e0172900.
PMID: 28257515
Introduction: The immune system acts on different metabolic tissues that are implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Leptin and linoleic acid have the ability to potentially...
10.
Piratvisuth T, Komolmit P, Chan H, Tanwandee T, Sukeepaisarnjaroen W, Pessoa M, et al.
Drugs Context
. 2016 Jul;
5:212294.
PMID: 27403192
Background: A 2-year roadmap study was conducted to evaluate the efficacy and safety of tenofovir intensification at Week 24 in patients with chronic hepatitis B (CHB) receiving telbivudine. Scope: A...